SDC1 and Miyoshi myopathy: More recently, Liu et al. [78] reported that CD138+ MM cells are a major source of Hh ligand SHH and autocrine SHH enhanced MM cells proliferation and drug resistance, indicating that the myeloma autocrine Hh signaling pathway was a promising therapeutic target in MM.